TREA

88283784 - UNIFYING CANCER CARE

Follow

Information

  • Trademark
  • 88283784
  • Serial Number
    88283784
  • Filing Date
    January 31, 2019
    5 years ago
  • Transaction Date
    May 16, 2024
    5 months ago
  • Status Date
    July 18, 2022
    2 years ago
  • Published for Opposition Date
    April 20, 2021
    3 years ago
  • Location Date
    May 16, 2024
    5 months ago
  • Status Code
    606
  • Current Location
    TMEG LAW OFFICE 108
    Employee Name
    ASKEW, MEGAN RUTH
  • Attorney Docket Number
    271659509110
    Attorney Name
    Anessa O. Kramer
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
UNIFYING CANCER CARE
Case File Statements
  • GS0411: Education services, namely, providing training and on-demand on-line training in the form of courses, seminars and workshops in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Education services, namely, providing non-downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions
  • GS0091: Downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable or recorded computer software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; downloadable or recorded computer software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis
  • GS0051: Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluids
  • GS0161: Printed publications, namely, newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions
  • GS0011: Pre-packaged medical tests kits and medical test kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes and also containing clinical medical reagents and antibodies for use in disease testing for clinical medical laboratory use
  • GS0441: Medical information; medical diagnostic testing services in the field of human disease and human medical conditions; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and the delivery of scientific and medical test results; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes
  • DS0000: "CANCER CARE"
  • GS0421: Medical laboratories; medical laboratory services; Medical and scientific research information in the field of human disease and human medical conditions; medical laboratories, medical laboratory services; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services; providing information, interactive information, and reports to others in the field of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing information to others in the field of scientific testing and research and clinical scientific testing; providing an internet website portal featuring information in the field of scientific testing and research, medical research, and clinical scientific testing; providing cloud-based information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; providing online non-downloadable Internet-based software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; Software as a service (SAAS) services featuring software for medical testing and analysis of medical test results; Software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; genetic mapping for scientific purposes, namely, gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer
Case File Event Statements
  • 2/22/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/4/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/13/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/3/2019 - 5 years ago
    7 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 4/13/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/13/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/13/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/23/2019 - 5 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/30/2019 - 5 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 10/1/2019 - 5 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/1/2019 - 5 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/23/2019 - 5 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/15/2021 - 3 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/15/2021 - 3 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/15/2021 - 3 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/15/2021 - 3 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/15/2021 - 3 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/23/2019 - 5 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/23/2019 - 5 years ago
    14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/28/2020 - 4 years ago
    15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 11/10/2020 - 3 years ago
    16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 3/31/2021 - 3 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/20/2021 - 3 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/20/2021 - 3 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/19/2021 - 2 years ago
    27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/15/2021 - 3 years ago
    25 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/19/2021 - 2 years ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/19/2021 - 2 years ago
    33 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/19/2021 - 2 years ago
    26 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/19/2021 - 2 years ago
    30 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/19/2021 - 2 years ago
    29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/19/2021 - 2 years ago
    28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/30/2021 - 2 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/13/2022 - 2 years ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/13/2022 - 2 years ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/13/2022 - 2 years ago
    38 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/29/2021 - 2 years ago
    32 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/29/2021 - 2 years ago
    34 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/16/2024 - 5 months ago
    41 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/18/2022 - 2 years ago
    39 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/18/2022 - 2 years ago
    40 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6